RxDoctor Payments Data

Karim Sabeh, MD

Orthopaedic Surgery · Miami, FLNPI 1134461965

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.7%), education and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 60.5% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $49,918, 7.2 times the $6,954 reported in 2019.

$76,871in general payments, 2019–2025

Across 123 payments — averaging $624.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$46K
  • Zimmer Biomet$29K
  • Stryker$1K
  • Johnson & Johnson$222
  • Applied Medical Resources Corporation$137
  • Bioventus LLC$41
  • plus $140 from 5 others

What the payments were for

  • Consulting fees$36,67548%
  • Travel & lodging$5,2247%
  • Food & beverage$6,1538%
  • Education$28,82037%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$76,871 in reported general payments places this provider in the 85th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida →

Medicare billing

Part B allowed, 2024
$358,496
Medicare patients
642
Services billed
7,454

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib67$1,350
Diclofenac Sodium27$1,081
Meloxicam165$501
Oxycodone Hcl81$442
Gabapentin35$279
Tramadol Hcl53$210
Methylprednisolone24$202
Omeprazole30$197
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$191
Ondansetron Hcl24$73
Cyclobenzaprine Hcl12$55
Amoxicillin12$19

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →